Opus132
Opus 132 develops end-to-end solutions aimed at improving health spans for individuals with rare genetic conditions. The company focuses on addressing the significant gaps in diagnosis and treatment availability for these patient populations. By leveraging scientific understanding, Opus 132 seeks to provide pathways to effective therapies where few currently exist.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Opus 132 develops end-to-end solutions aimed at improving health spans for individuals with rare genetic conditions. The company focuses on addressing the significant gaps in diagnosis and treatment availability for these patient populations. By leveraging scientific understanding, Opus 132 seeks to provide pathways to effective therapies where few currently exist.